HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unilever creates personal-care unit

This article was originally published in The Rose Sheet

Executive Summary

Unilever will close its Chicago offices by July 2010, combining the antiperspirants, deodorant and hair-care group based there with skin care to form a single personal-care division based at its Englewood Cliffs, N.J., North American headquarters, firm announced Nov. 10. "Over the last few years, we have made significant progress in bringing Unilever teams together in North America," Unilever Americas President Michael B. Polk states in a release. "The decision to create a single [personal-care] unit within the U.S. business is in line with this progress, and will leverage the resources and capabilities across our [personal-care] brands to drive further growth." The firm, which markets brands including Axe, Dove and Vaseline, has "integrated a number of businesses" between 2006 and 2009 to leverage resources and drive growth, the release notes

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016556

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel